Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of The ShOckwave Medical Peripheral Lithoplasty® System Used to Treat Moderate and Severely CalcIfied FemOropopliteal Arteries in ChiNese Patients (SOLUTION Trial)

NCT05434676 is registered in ClinicalTrials.gov with Genesis Medtech Corporation as lead sponsor.

NCT NCT05434676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05434676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of The ShOckwave Medical Peripheral Lithoplasty® System Used to Treat Moderate and Severely CalcIfied FemOropopliteal Arteries in ChiNese Patients (SOLUTION Trial)
Lead sponsor
Genesis Medtech Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
June 15, 2021
Completion date
July 30, 2023
Enrollment
20 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

calcifications vascular, peripheral arterial disease